These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18057270)

  • 1. Medication taking and diabetes: a systematic review of the literature.
    Odegard PS; Capoccia K
    Diabetes Educ; 2007; 33(6):1014-29; discussion 1030-1. PubMed ID: 18057270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic literature review of methodologies used to assess medication adherence in patients with diabetes.
    Clifford S; Perez-Nieves M; Skalicky AM; Reaney M; Coyne KS
    Curr Med Res Opin; 2014 Jun; 30(6):1071-85. PubMed ID: 24432796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between health beliefs and medication adherence among patients with type 2 diabetes.
    Alatawi YM; Kavookjian J; Ekong G; Alrayees MM
    Res Social Adm Pharm; 2016; 12(6):914-925. PubMed ID: 26706405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in medication adherence and self-management of diabetes with a clinical pharmacy program: a randomized controlled trial in patients with type 2 diabetes undergoing insulin therapy at a teaching hospital.
    Cani CG; Lopes Lda S; Queiroz M; Nery M
    Clinics (Sao Paulo); 2015 Feb; 70(2):102-6. PubMed ID: 25789518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ARMS-D out performs the SDSCA, but both are reliable, valid, and predict glycemic control.
    Mayberry LS; Gonzalez JS; Wallston KA; Kripalani S; Osborn CY
    Diabetes Res Clin Pract; 2013 Nov; 102(2):96-104. PubMed ID: 24209600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonadherence to insulin therapy in low-income, type 2 diabetic patients.
    Lerman I; Díaz JP; Ibarguengoitia ME; Pérez FJ; Villa AR; Velasco ML; Cruz RG; Rodrigo JA
    Endocr Pract; 2009; 15(1):41-6. PubMed ID: 19211396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with medication adherence to oral hypoglycaemic agents in different ethnic groups suffering from type 2 diabetes: a systematic literature review and suggestions for further research.
    Peeters B; Van Tongelen I; Boussery K; Mehuys E; Remon JP; Willems S
    Diabet Med; 2011 Mar; 28(3):262-75. PubMed ID: 21309834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007 Jun; 29(6 Pt 1):1236-53. PubMed ID: 18036387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c).
    Cohen HW; Shmukler C; Ullman R; Rivera CM; Walker EA
    Diabet Med; 2010 Feb; 27(2):210-6. PubMed ID: 20546266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to medication adherence in poorly controlled diabetes mellitus.
    Odegard PS; Gray SL
    Diabetes Educ; 2008; 34(4):692-7. PubMed ID: 18669811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program.
    Lawrence DB; Ragucci KR; Long LB; Parris BS; Helfer LA
    J Manag Care Pharm; 2006; 12(6):466-71. PubMed ID: 16925454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
    Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacist's role in maintaining adherence to insulin therapy in type 2 diabetes mellitus.
    Vivian EM
    Consult Pharm; 2007 Apr; 22(4):320-32. PubMed ID: 17658964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital.
    Ayele AA; Tegegn HG; Ayele TA; Ayalew MB
    BMJ Open Diabetes Res Care; 2019; 7(1):e000685. PubMed ID: 31321061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to multiple medications in the TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth) cohort: effect of additional medications on adherence to primary diabetes medication.
    Shah R; McKay SV; Levitt Katz LE; El Ghormli L; Anderson BJ; Casey TL; Higgins L; Izquierdo R; Wauters AD; Chang N;
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):191-198. PubMed ID: 31809265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing barriers to medication adherence in underserved patients with diabetes in Texas.
    Bailey GR; Barner JC; Weems JK; Leckbee G; Solis R; Montemayor D; Pope ND
    Diabetes Educ; 2012; 38(2):271-9. PubMed ID: 22316643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence in young adults with youth-onset type 2 diabetes: iCount, an observational study.
    Trief PM; Kalichman SC; Wang D; Drews KL; Anderson BJ; Bulger JD; Weinstock RS
    Diabetes Res Clin Pract; 2022 Feb; 184():109216. PubMed ID: 35085644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.
    Iglay K; Cartier SE; Rosen VM; Zarotsky V; Rajpathak SN; Radican L; Tunceli K
    Curr Med Res Opin; 2015; 31(7):1283-96. PubMed ID: 26023805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Tailored Cognitive-Behavioural Intervention Produces Comparable Reductions in Regimen-Related Distress in Adults With Type 2 Diabetes Regardless of Insulin Use: 12-Month Outcomes From the COMRADE Trial.
    Lutes LD; Cummings DM; Littlewood K; Le MT; Kirian K; Patil S; Solar C; Carraway M; Hambidge B
    Can J Diabetes; 2020 Aug; 44(6):530-536. PubMed ID: 32792107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.